Extracellular glycerol regulates the cardiac energy balance in a working rat heart model

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 3, 2007, Pages

  Gambert, Ségolène ^a   Héliès Toussaint, Cécile ^a   Grynberg, Alain ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

oxidation; Energy metabolism; Glucose; Palmitate; Phospholipids

Indexed keywords

GLUCOSE; GLYCEROL; GLYCEROLIPID; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ELECTROCARDIOGRAM; ENERGY BALANCE; ENERGY METABOLISM; ENERGY RESOURCE; ENERGY YIELD; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART RATE; LIPOGENESIS; MOUSE; NONHUMAN; OXIDATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ANIMALS; ENERGY METABOLISM; GLYCEROL; HEART; HOMEOSTASIS; MALE; MODELS, ANIMAL; MYOCARDIUM; RATS; RATS, WISTAR;

EID: 33847720713     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00563.2006     Document Type: Article

References (28)

1. Dagnelie. Théories et Méthodes Statistiques. Gembloux, Belgium: Les Presses Agronomique de Gembloux, 1975.
2. Demaison L, Fantini E, Sentex E, Grynberg A, Athias P. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol 76: 31B-37B, 1995.
3. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 26: 949-958, 1994.
4. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
5. Gambert S, Helies-Toussaint C, Grynberg A. Regulation of intermediary metabolism in rat cardiac myocyte by extracellular glycerol. Biochim Biophys Acta 1736: 152-162, 2005.
6. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 273: 29530-29539, 1998.
7. Grynberg A. Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents. Curr Pharm Des 11: 489-509, 2005.
8. Hauton D, Bennett MJ, Evans RD. Utilisation of triacylglycerol and nonesterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochim Biophys Acta 1533: 99-109, 2001.
9. Hubinger A, Weikert G, Wolf HP, Gries FA. The effect of etomoxir on insulin sensitivity in type 2 diabetic patients. Horm Metab Res 24: 115-118, 1992.
10. Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res 95: 568-578, 2004.
11. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86: 580-588, 2000.
12. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 39: 718-725, 2002.
13. Lloyd S, Brocks C, Chatham JC. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am J Physiol Heart Circ Physiol 285: H163-H172, 2003.
14. Lopaschuk GD. Targets for modulation of fatty acid oxidation in the heart. Curr Opin Investig Drugs 5: 290-294, 2004.
15. Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res 93: e33-e37, 2003.
16. Lopaschuk GD, Barr RL. Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart. Mol Cell Biochem 172: 137-147, 1997.
17. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144, 1993.
18. McNeil PL, Steinhardt RA. Loss, restoration, and maintenance of plasma membrane integrity. J Cell Biol 137: 1-4, 1997.
19. Opie L. The Heart: Physiology and Metabolism. New York: Raven, 1991, p. 1-500.
20. Rupp H, Zarain-Herzberg A, Maisch B. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz 27: 621-636, 2002.
21. Schmitz FJ, Rosen P, Reinauer H. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir. Horm Metab Res 27: 515-522, 1995.
22. Sentex E, Helies-Toussaint C, Rousseau D, Lucien A, Ferrary E, Grynberg A. Influence of trimetazidine on the synthesis of complex lipids in the heart and other target organs. Fundam Clin Pharmacol 15: 255-264, 2001.
23. Sentex E, Sergiel JP, Lucien A, Grynberg A. Trimetazidine increases phospholipid turnover in ventricular myocyte. Mol Cell Biochem 175: 153-162, 1997.
24. Sentex E, Sergiel JP, Lucien A, Grynberg A. Is the cytoprotective effect of trimetazidine associated with lipid metabolism? Am J Cardiol 82: 18K-24K, 1998.
25. Stanley WC, Marzilli M. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine. Fundam Clin Pharmacol 17: 133-145, 2003.
26. Tildon JT, Roeder LM. Glycerol oxidation in rat brain: subcellular localization and kinetic characteristics. J Neurosci Res 5: 7-17, 1980.
27. Vance JE, Vance DE. Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol 82: 113-128, 2004.
28. Yamashita H, Itsuki A, Kimoto M, Hiemori M, Tsuji H. Acetate generation in rat liver mitochondria; acetyl-CoA hydrolase activity is demonstrated by 3-ketoacyl-CoA thiolase. Biochim Biophys Acta 1761: 17-23, 2006.